TNGX | Tango TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$23.17
+$1.41 (+6.48%)

Tango Therapeutics (TNGX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2025, but the two have been closing on each other and a death cross is projected within 20 bars. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
above both $22.72 vs 50 $19.96 / 200 $9.74
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 16 Feb 2026 ยท projected 25 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $23.79 vs 50 $23.35 / 200 $25.95
Projection
No cross projected
Test
No active test
Last cross
Death cross 1 Sep 2026 ยท projected 16 bars out

Cross history

15
crosses on record since 2022
8 golden7 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Sep 2026Death4-hour16 bars outNot tested
week of 16 Feb 2026Golden moderateweekly25 bars outNot tested
14 Jul 2025Golden steepdaily30 bars outNot tested
9 Jun 2025Golden4-hour25 bars outโ€”
9 Oct 2024Deathdaily19 bars outNot tested

About TNGX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$66.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.